German rearmament tests time, money and resolve
23 May Foreign & Security Policy

German rearmament tests time, money and resolve

As Germany prepares to spend 5% of GDP on defence, Chancellor Friedrich Merz must overcome scepticism both within his governing coalition and in the country at large.
by Arno Van Rensbergen
‘The West created Vučić’: Serbian journalists say repression is tightening
21 May Foreign & Security Policy
‘The West created Vučić’: Serbian journalists say repression is tightening
Op-ed: When it comes to the DMA, Europe must show its teeth
22 May EU Institutions
Op-ed: When it comes to the DMA, Europe must show its teeth
Op-ed: Europe’s existential choice
21 May Foreign & Security Policy
Op-ed: Europe’s existential choice
Medicines in Europe: We must address affordability and availability
13 Dec
Medicines in Europe: We must address affordability and availability
The EU market for medicines remains fragmented. Member States don't have the same access to sometimes life-saving medicines. This model is not sustainable, argues MEP Alex Agius Saliba.
Biomethane’s boundless potential to decarbonise heavy-duty transport in the EU market Partner Content
12 Dec
Biomethane’s boundless potential to decarbonise heavy-duty transport in the EU market
The European Commission’s has ambitious plans to reduce Heavy Duty Vehicle (HDV) emissions by 90% by 2040, but how can the industry get there?
The art of wellbeing: How Europe is using culture for its health benefits
12 Dec Culture & Arts
The art of wellbeing: How Europe is using culture for its health benefits
Programmes using art for its health benefits are popping up all over Europe. The trend even has the support of the European institutions and the World Health Organisation
Bitter pills: Europe struggles with medicine shortages
11 Dec EU Institutions
Bitter pills: Europe struggles with medicine shortages
A fragile supply chain and increased demand are causing a shortfall in the EU’s stock of critical medicines. Gabriela Galindo looks at how policymakers can stabilise the situation
In conversation with the Alexion team working to help rare diseases patients Partner Content
11 Dec
In conversation with the Alexion team working to help rare diseases patients
At the World Orphan Drug Congress 2023, we caught up with some of the Alexion – AstraZeneca Rare Disease team to hear more about rare diseases and how the EU can best support patients.
Antimicrobial resistance is the next global health challenge
08 Dec
Antimicrobial resistance is the next global health challenge
“The sooner we act, the more damage we can prevent in the future”, says MEP Nicu Stefanuta
On the ground in Moldova: how the country fights tuberculosis
07 Dec EU Institutions
On the ground in Moldova: how the country fights tuberculosis
The country continues to grapple with high tuberculosis rates, but joining the EU could help fight the disease, reports Julia Kaiser from Moldova, where she travelled with The Global Fund
Changing perspectives and alternative thinking critical to advancing discussions around animal testing replacements Partner Content
06 Dec
Changing perspectives and alternative thinking critical to advancing discussions around animal testing replacements
MEP Jutta Paulus reflects on the barriers to implement new technologies to replace animal testing at PrecisionTox's Informative Breakfast on research and policy insights exploring the barriers to New Approach Methodologies (NAMs) for chemical risk assessment at the European Parliament
No health without brain health Partner Content
06 Dec EU Institutions
No health without brain health
Whilst an estimated 179 million Europeans live with brain conditions, brain disorders still lack the awareness and recognition in the EU
Air pollution in Europe: The silent killer
06 Dec Energy & Environment
Air pollution in Europe: The silent killer
While pollution kills thousands of Europeans each year, the European Union is failing to meet the air quality targets set by the World Health Organisation, Marilyn Wright reports
Towards a healthier Europe with medical technology Partner Content
06 Dec
Towards a healthier Europe with medical technology
How the next generation of EU policymakers can
empower patients and inspire innovation
Fostering brain research and innovation in the EU Partner Content
06 Dec
Fostering brain research and innovation in the EU
Now is the time for the EU to prioritise research and innovation into brain diseases
Boosting innovation in Europe to deliver faster patient access to treatments Partner Content
06 Dec
Boosting innovation in Europe to deliver faster patient access to treatments
With an ageing population and rising demand, ensuring fair access to new medicines and treatments is high on the political agenda. The Parliament sat down with Ilya Yuffa, Executive Vice President, and President, Lilly International, to learn more about why innovation is key to delivering better health outcomes for European citizens.
A patient driven definition of Unmet Medical Need in migraine Partner Content
05 Dec
A patient driven definition of Unmet Medical Need in migraine
Elena Ruiz de la Torre, Executive Director of the European Migraine Headache Alliance (EMHA) spoke to Ingrid Mcgowan, Head of International Patient Advocacy at AbbVie to discuss a patient driven definition of Unmet Medical Need in migraine.
Mental health in Europe: it is time for a strategy
05 Dec EU Institutions
Mental health in Europe: it is time for a strategy
In June, the Commission launched a Mental Health Communication. While this step is an admirable advancement, there is room for improvement, argues Dr. Alessandro Gallina from the European Public Health Alliance
Migraine’s in Europe and their adverse prevalence in women Partner Content
05 Dec EU Institutions
Migraine’s in Europe and their adverse prevalence in women
A European Migraine Action Plan is needed to tackle an underestimated medical condition impacting 1 in 7 people globally.
Hi-tech health: How AI is revolutionising healthcare
04 Dec Technology
Hi-tech health: How AI is revolutionising healthcare
From faster diagnosis to new drug development, AI is driving exciting breakthroughs in medical services. But there are also calls for caution. Sarah Schug reports
Self-Care can contribute to finding solutions to AMR Partner Content
04 Dec
Self-Care can contribute to finding solutions to AMR
Making antimicrobial medicines for minor infections prescription-only could undermine the health and wellbeing of European citizens
Keeping rare disease patients at the heart of the EU’s review of the pharmaceutical legislation Partner Content
04 Dec
Keeping rare disease patients at the heart of the EU’s review of the pharmaceutical legislation
The 2023 World Orphan Drug Congress brought together over 1600 members of the rare disease community to take a look at what needs to be done to best support rare disease patients. What were the key lessons learned across the congress?
Turning research into policy to tackle Europe’s NCD crisis Partner Content
01 Dec
Turning research into policy to tackle Europe’s NCD crisis
Europe’s health systems are under increasing strain. Rising levels of need demand new approaches that focus on disease prevention and early detection, particularly of non-communicable diseases (NCDs). A major new report from the Partnership for Health System Sustainability and Resilience (PHSSR)’s EU Expert Advisory Group has now highlighted a way forward that could help shape Europe’s health systems of tomorrow
Empowering diverse voices: a pledge for inclusive choices
01 Dec
Empowering diverse voices: a pledge for inclusive choices
The Brussels Binder, a database of female experts, seeks to relegate male-only panels to history
Unlocking resources and hope for patients with rare diseases through practical policy Partner Content
29 Nov
Unlocking resources and hope for patients with rare diseases through practical policy
Some believe a recent legislation update proposal will undermine access to medicines for millions of Europeans suffering from rare diseases by disincentivising research investment. Will ongoing revisions enable continued innovation?
Europe’s hidden burden: why the EU must do more to tackle skin diseases Partner Content
29 Nov
Europe’s hidden burden: why the EU must do more to tackle skin diseases
185 million Europeans suffer from skin diseases yet the burden these diseases place on patients, healthcare systems and society often goes unnoticed and results in lack of prioritisation at the level of policymakers. Dermatologists, patients, policymakers and industry stakeholders gathered to discuss what needs to be done to accelerate Europe’s response to skin diseases.
Europe's health commissioner dives in head first
28 Nov EU Institutions
Europe's health commissioner dives in head first
"We need to remain vigilant and be ready for all scenarios," Stella Kyriakides told The Parliament